Public Board of Directors papers 27.01.22

Agenda item 02/22b

Board of Directors meeting Thursday 27 th January 2022

Subject / Title

NHS Regional Office’s conclusions following the Rapid Review of the Research and Innovation Division

Author(s)

Deputy CEO/Medical Director and Executive Team

Presented by

Chairman and CEO

Summary / purpose of paper

To bring the NHS Regional Office’s conclusions following the “Rapid Review of the Research and Innovation Division” to the attention of the board To confirm the action taken in relation to the R+I Division whilst awaiting the findings of the “Rapid Review” To confirm that all recommendations of the “Rapid Review” had been anticipated and addressed or are in progress ahead of receipt of the report Note the conclusions of The NHS Regional Office including that no regulatory intervention or other action is required 2. Note the comments and responses to the recommendations 3. Note the learning points arising from our experience of the past 2 years 4. To continue to revise and update policies in line with good practice 1. Letter from Amanda Doyle, NHS Regional Director 2. Report of Rapid Review Team into the R+I Division at The Christie The serious allegations carried a risk to our reputation and the confidence of patients in our services if incorrectly repeated in the media. However, The Rapid Review has found t here is no evidence of wrong doing by staff and board members of The Christie in relation to allegations of bribery and embezzlement , our clinical trials performance has been maintained in the top national category during the pandemic, our Freedom to Speak Up approach is in line with national requirements, our staff survey results and our Speaking Up Index are better than peer group benchmarks, there have been no contraventions of data protection requirements, information has been considered by the board of directors in a timely way. The board of directors is invited to: 1.

Recommendation(s)

Background Papers (Enclosed)

Risk Score

12